Sorry, you need to enable JavaScript to visit this website.

DEPO-SUBQ PROVERA 104® (medroxyprogesterone acetate injectable suspension) Boxed Warning

WARNING: LOSS OF BONE MINERAL DENSITY

  • Women who use depo-subQ provera 104 may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be completely reversible [see Warnings and Precautions (5.1)].
  • It is unknown if use of depo-subQ provera 104 during adolescence or early adulthood, a critical period of bone accretion, will reduce peak bone mass and increase the risk for osteoporotic fracture in later life [see Warnings and Precautions (5.1)].
  • Depo-subQ provera 104 is not recommended as a long-term (i.e., longer than 2 years) birth control method or medical therapy for endometriosis-associated pain unless other options are considered inadequate [see Indications and Usage (1) and Warnings and Precautions (5.1)].

What's New

No Current Announcements.

Search

Please enter your search term(s) for DEPO-SUBQ PROVERA 104®